Sanofi Financials

Market Capitalization €124.08 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.57
Forward PE	11.48
Price to Sales TTM	€2.56
Price to Book MRQ	€1.70
Enterprise to Revenue	2.91
Enterprise to EBITDA	11.27

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	9.30%
Operating Margin	28.81%
Return on Assets TTM	4.27%
Return on Equity TTM	7.26%

Income Statement

Revenue TTM	€48,445,001,728
Revenue per Share TTM	€38.71
Quarterly Revenue Growth	11.50%
Gross Profit TTM	€33,482,999,808
EBITDA	€12,476,000,000
Net Income to Common TTM	€4,505,999,872
Diluted EPS TTM	€3.59
Quarterly Earnings Growth YoY	11.50%

Balance Sheet

Total Cash MRQ	€6,794,999,808
Total Cash per Share MRQ	€5.43
Total Debt MRQ	€
Total Debt to Equity MRQ	32.54
Current Ratio MRQ	1.00
Book Value per Share MRQ	€58.10

Cash Flow

Operating Cash Flow TTM	€10,325,000,000
Levered Free Cash Flow TTM	€12,137,000,000

SAN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,253,590,016
Float Shares	1,100,558,536
Avg 10 Volume	1,346,269
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	12.04%
% Held by Institutions	42.46%

Stock Price Summary

Beta	0.45
Fifty Two Week Low	€84.93
Fifty Two Week High	€106.14
Fifty Two Week Change	7.48%
Day 50 MA	€92.91
Day 200 MA	€94.67

Dividends and Splits

Forward Annual Dividend Rate	€15.04
Forward Annual Dividend Yield	15.02%
Trailing Annual Dividend Rate	€3.76
Trailing Annual Dividend Yield	3.75%
Payout Ratio	104.74%
Dividend Date
Ex Dividend Date	2024-05-13
Last Split Factor
Last Split Date